# PKC412 and 5-Azacytidine

> **NCT01202877** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 54 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** 5-azacytidine
- **DRUG:** PKC412

## Key facts

- **NCT ID:** NCT01202877
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2018-10-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202877, "PKC412 and 5-Azacytidine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01202877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*